Skip to Site Navigation Skip to Main Content Skip to Footer

Cancer Pharmacology - MSc

Why study this course?

London Met’s Cancer Pharmacology master's course explores the nature of cancer at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and how they work. By the end of the MSc, you will have developed a deep understanding of how chemotherapeutic agents are used to target and kill cancer cells as part of a central strategy in the treatment of cancers.

In the most recent (2015-16) Destinations of Leavers from Higher Education (DLHE) survey, 100% of graduates from this course were in work or further study within six months.

Open all

With worldwide cancer rates increasing and expected to reach 22 million new cases per year by 2030, this postgraduate course introduces you to how radiotherapy, surgery and chemotherapy have a vital role to play in prolonging the lives of patients.

We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving. You’ll also review the biology of cancer with respect to genetics, pathological considerations and the molecular changes within cells which are associated with the progression of the disease.

You'll be taught by staff who are experienced researchers in areas such as cancer biology,  immunology, genetics and bioinformatics. They will help you learn how to collect, analyse, interpret and understand scientific data you must make use of in the cancer pharmacology field. This ensures you’ll not only improve your intellectual knowledge but your practical skills as well.

Your laboratory-based project will be conducted in our £30 million Science Centre. This includes access to extensive cell culture facilities, electrophoresis equipment, polymerase chain reaction (PCR) cyclers and high performance liquid chromatography (HPLC) instrumentation.

Overall, this programme of advanced study provides you with the necessary skills, knowledge and understanding for you to pursue a career in anti-cancer drug development.

Assessment

Assessment on this master's course is completed through a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

You will be required to have:

  • at least a lower second class (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics (these will be considered on an individual basis)

All applicants must be able to demonstrate proficiency in the English language. Applicants who require a Tier 4 student visa may need to provide a Secure English Language Test (SELT) such as Academic IELTS. For more information about English qualifications please see our English language requirements.

The modules listed below are for the academic year 2017/18 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:

The MSc is a one year, full-time course involving 30 weeks of taught modules divided into two 15-week semesters. The part-time mode follows a similar pattern over two years. You take five core modules, one optional module plus a research project.

Core modules:

  • Molecular Oncology
  • Cancer Pharmacology
  • Cancer: Diagnosis & Treatment
  • Molecular Genetics
  • Scientific Frameworks for Research
  • Research Project

Optional modules:

  • Drug Discovery Technology
  • Advanced Drug Formulation Technologies
  • Bioinformatics and Molecular Modelling

Our graduates primarily go on to pursue a career in anti-cancer drug development in academia or the pharmaceutical industry. The programme also provides an excellent basis for further research or study.

Between 2016 and 2020 we're investing £125 million in the London Metropolitan University campus, moving all of our activity to our current Holloway campus in Islington, north London. This will mean the teaching location of some courses will change over time.

Whether you will be affected will depend on the duration of your course, when you start and your mode of study. The earliest moves affecting new students will be in September 2017. This may mean you begin your course at one location, but over the duration of the course you are relocated to one of our other campuses. Our intention is that no full-time student will change campus more than once during a course of typical duration.

All students will benefit from our move to one campus, which will allow us to develop state-of-the-art facilities, flexible teaching areas and stunning social spaces.

Please note, in addition to the tuition fee there may be additional costs for things like equipment, materials, printing, textbooks, trips or professional body fees.

Additionally, there may be other activities that are not formally part of your course and not required to complete your course, but which you may find helpful (for example, optional field trips). The costs of these are additional to your tuition fee and the fees set out above and will be notified when the activity is being arranged.

How to apply

Use the apply button to begin your application.

Please note, fees and course details may be subject to change.

When to apply

You are advised to apply as early as possible as applications will only be considered if there are places available on the course.

Fees and key information

Postgraduate
Please select your entry point to display the fee

News and success stories

Meet the team


Visit us